Announcement on the Progress of Drug Clinical Trials and Orphan Drug Qualification Accreditation by FDA for a Wholly-owned Subsidiary

About this update from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Announcement on the Progress of Drug Clinical Trials and Orphan Drug Qualification Accreditation by FDA for a Wholly-owned Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Vcanbio Cell & Gene Engineering Corp., Ltd. Class A